Where Science Meets You
Meet the Team
Founder & Lead Scientist
Szilard Voros, MD
Szilard Voros, MD, FACC, FAHA, is a physician, cardiologist, geneticist, and serial entrepreneur. In 2012, he founded Global Genomics Group (G3), a precision-medicine-based biotechnology company, developing and commercializing novel drugs, nutraceuticals, and blood based biomarkers in common, chronic diseases, as well as for prevention, wellness, and life extension.
​
​
​
​
Founder
Karl Blass
Karl is a self-made entrepreneur with over 15 years of hard-won experience in healthcare and biotech. A proactive thinker and problem solver who thrives in high-stakes environments, Karl doesn’t just adapt to change—he anticipates it. His ability to pivot and execute under pressure is key to his success. Passionate about healthcare, biotech innovation, and cutting-edge technology, Karl believes his most valuable asset is his drive to effect change for the good of humanity. At PUER, Karl navigates our team through complex regulations, funding rounds, and forges strategic partnerships, providing our brilliant scientists and doctors with critical operational expertise in a highly competitive and regulated market.
​
​
​
​
Partner - Endocrinology
Kate S. Wheeler, MD
As an endocrinologist for almost 20 years, I enjoy working with patients with a wide array of issues, many with complex genetics. PUER offers an opportunity for me to ascertain an unprecedented amount of genetic and gene processing information to enable the application of true precision medicine. To be part of the team, to apply the PUER program, to discover, prevent, and treat disease, is a culminating opportunity that I believe will be the next major chapter in medical care.
​​
​
​
Advisor - Oncology, Pathology, and Molecular Genetics
Malak Althgafi, MD, MBA
Dr. Malak Althgafi, a Professor and Director of the Neuropathology Division and Fellowship. As a physician, pathologist, and molecular geneticist, her research endeavors are aimed at revolutionizing cancer treatment through precision medicine.
​
Beyond her academic and research pursuits, Dr. Althgafi is an entrepreneurial force, having founded two companies in the genomics space. These ventures further demonstrate her commitment to applying scientific discoveries to practical applications in cancer diagnosis and treatment. Dr. Althgafi’s role as an advisor to international organizations on genomics and precision medicine underscores her global impact on the field.
​​​​​
​
Advisor - Psychiatry
Viktor Voros, MD, PhD
Viktor Voros MD, PhD, Associate Professor, is a physician, clinical psychiatrist, and researcher. His major clinical and scientific interests are affective disorders and the psychiatric and psychological aspects of ageing and dementias. He is the co-founder of a Dedicated Research Centre in the field of psychiatry, neuropsychiatry and addictology. He serves as primary investigator in clinical trials, and he is a consultant for different pharmaceutical and biotech companies. He is a member of several scientific societies, and published his extensive research in different scientific journals, books and congresses.​
​​
​
Advisor - Nutritionist
Meriah Schoen, PhD, RDN
Meriah Schoen, PhD, RDN, is a clinical researcher and registered dietitian nutritionist who specializes in inherited metabolic disorders. Her research is focused on evaluating factors that contribute to metabolic variability and impact treatment efficacy. She utilizes her background in metabolic nutrition to develop and optimize dietary strategies to improve health outcomes.
​​​​
​
​
​
​
Advisor - Nutritionist
Lisa R. Young, PhD, RDN
Lisa R. Young, PhD, RDN is an internationally recognized nutritionist and portion control expert. With over three decades of experience, she is an adjunct professor of nutrition at New York University, author, and nutrition advisor to corporations. As a registered dietitian nutritionist in private practice, Dr. Young counsels patients on a wide variety of nutrition and health issues, respecting each individual's unique needs while guiding them towards food and lifestyle choices that support their health. Dr. Young is the author of Finally Full, Finally Slim & The Portion Teller Plan and is regularly called upon by major media outlets as an expert voice on nutrition and health.
​
​
Advisor - Nutritionist
Orsolya M. Palacios, RD, PhD
Orsolya M Palacios, RD, PhD, is a molecular nutrition scientist and registered dietitian with over 20 years experience researching the link between diet, nutrigenomics, metabolism and body weight. Her roles have included designing, managing and leading nutrition research studies, and translating the science into meaningful applications for the biomedical industries. She is also the cofounder of DietCypher® and its personalized weight loss diet program, iLivTru®.
​
​
​
​
​
Advisor - Exercise Physiologist
Gwénaëlle Begue, PhD
As an exercise physiologist for almost 15 years, my research foci intersect physiology and molecular biology to explore cardiovascular and skeletal muscle health with exercise at the whole body to the gene level. Using an integrative and person-specific approach, I have strived to develop personalized exercise programs for disease modifications, increase healthspan, longevity, and performance in diverse individuals. The uniqueness of the PUER program will revolutionize the field of exercise is medicine.
​
​
​
​
​
Advisor - Exercise Physiologist
Rachelle Reed, PhD, MS, ACSM-EP
Rachelle holds a B.A., M.S., and Ph.D. in exercise physiology, completed postdoctoral training in exercise psychology, and is also an ACSM Certified Exercise Physiologist. Rachelle is part-time teaching faculty at The University of Georgia and serves as the Chair for ACSM's Continuing Professional Education Committee. She works as a leading industry scientist, bridging the gap between the wellness and research spaces to provide personalized, evidence-based exercise programming and science communication.
​
​
​
​
​
.png)
Advisor - Bioinformatics
Michael R. Barnes, PhD
I am a computational biologist with extensive experience in bioinformatics, genomics, and stratified medicine, spanning both industry and academia. After 13 years leading bioinformatics teams in pharmaceutical R&D, I transitioned to a new academic role leading the Centre for Translational Bioinformatics at Queen Mary University of London. My research bridges genomic biomarker discovery, drug development, and health data science, with a strong focus on translating omics insights into clinical and personalized medicine applications. As a Fellow of the Alan Turing Institute and Bioinformatics professor, I co-lead national and international initiatives leveraging AI and multi-omics to enhance disease stratification and therapeutic precision. My expertise in disease discovery aligns with PUER’s mission to apply and integrate high-dimensional biological data for personalized health optimization.
​
​
Michael@puer.health​​
​
.png)
Founder
Naomi Blass, JD
​After two decades in the legal field, I boldly transitioned into biotech--an industry where innovation and precision intersect. My background as an attorney honed my ability to analyze complex information, identify patterns, and craft strategic solutions. Creativity, however, has always been my most valuable asset. In addition to my legal expertise, I’m a writer and an artist. This creative mindset enhances my ability to see connections others might overlook, adapt to new challenges with agility, and communicate ideas in compelling ways. I’m delighted to bring that same analytical rigor and creative thinking to PUER.
​
​
Naomi@puer.health​​
​